BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171222
DTEND;VALUE=DATE:20180124
DTSTAMP:20260729T101342
CREATED:20171222T203715Z
LAST-MODIFIED:20171222T203855Z
UID:19508-1513900800-1516751999@ces.b2sg.org
SUMMARY:Staff Scientist
DESCRIPTION:Dr. Roberts’ lab studies the epigenetic regulation of gene expression. In particular we are studying chromatin-modifying proteins with a major focus on the SWI/SNF (BAF) chromatin remodeling/tumor suppressor complex and its relationship to cancers. Recent studies have revealed that genes encoding subunits of the SWI/SNF complex are mutated in over 20% of all cancers\, a rate approaching that of p53\, making this the most frequently mutated chromatin regulator in human malignancies. Research in the Roberts laboratory is designed to discover the mechanism by which SWI/SNF complex contributes to the regulation of gene expression and lineage specification\, and the mechanisms by which mutation of the tumor suppressor subunits drives cancer formation.  We also seek to identify specific vulnerabilities that are conferred by SWI/SNF mutation with the goal of identifying novel therapeutic opportunities. \nWe seek an ambitious scientist with a strong background in molecular biology\, cell biology\, cancer biology\, and/or genetics/epigenetics of tumorigenesis. Currently there are several projects ongoing in the laboratory involving the use of a variety of model systems that have been engineered in the lab including preclinical models\, primary cells\, and cell lines as well as the use of large sequencing\, CRISPR\, and drug vulnerability data sets. \n\nCandidates should have published in peer-reviewed journals. A prerequisite is experience in basic methods of molecular biology and biochemistry. \n\n\n\nMinimum Experience\n\n\n\n\nA minimum of five (5) years of relevant and productive postdoctoral research associate experience is required\n\n\n\n\nMinimum Education\n\n\n\n\nA Ph.D. in an appropriate scientific field is required
URL:https://ces.b2sg.org/event/stjude-22dec17/
LOCATION:St. Jude Children’s Hospital\, 262 Danny Thomas Pl\, Memphis\, TN\, 38105\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/stjude.jpg
END:VEVENT
END:VCALENDAR